obesity drug news today glp-1 october 2025 Weight-Loss Demonstration Begins July 2026 The Obesity-Drug Revolution Is Stalling

Hair Loss Solutions for GLP-1 Users

You may be consuming too much fiber

Case series 1: Under medical oversight, two individuals with Bardet-Biedl syndrome and type 2 diabetes mellitus lost 15% of their total body weight in a 3- and 5-month period, respectively, following a combination therapy of tirzepatide and setmelanotide

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans

Novo Nordisks share price rose by more than 4% on Monday on news of the launch, but is still down by 44% over the past year amid fierce competition from US rival Eli Lillys jabs Mounjaro and Zepbound